A gene signature-based approach identifies thioridazine as an inhibitor of phosphatidylinositol-3′-kinase (PI3K)/AKT pathway in ovarian cancer cells
2011 ◽
Vol 120
(1)
◽
pp. 121-127
◽
2008 ◽
Vol 18
(4)
◽
pp. 670-676
◽
2010 ◽
2005 ◽
Vol 4
(11)
◽
pp. 1764-1771
◽
2007 ◽
Vol 104
(2)
◽
pp. 470-479
◽
2012 ◽
Vol 29
(10)
◽
pp. 2874-2886
◽